Selected research
Market Structure
Global Anti-Counterfeit Packaging for Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Counterfeit Packaging for Healthcare market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-Counterfeit Packaging for Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Counterfeit Packaging for Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Counterfeit Packaging for Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Counterfeit Packaging for Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Counterfeit Packaging for Healthcare include 3M Company, Applied Dna Sciences, Inc, E. I. Dupont, Sicpa Holding SA, Zebra Technologies Corporation, Trutag Technologies Inc, CCL Industries Inc, Avery Dennison Corporation and Shiner International, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-Counterfeit Packaging for Healthcare market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Counterfeit Packaging for Healthcare and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Counterfeit Packaging for Healthcare sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Counterfeit Packaging for Healthcare market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Counterfeit Packaging for Healthcare Segment by Company
3M Company
Applied Dna Sciences, Inc
E. I. Dupont
Sicpa Holding SA
Zebra Technologies Corporation
Trutag Technologies Inc
CCL Industries Inc
Avery Dennison Corporation
Shiner International, Inc
R. R. Donnelley & Sons Company
Impinj, Inc
Essentra Plc
Anti-Counterfeit Packaging for Healthcare Segment by Type
Invisible Printing
Embedded Image
Digital Watermarks
Hidden Marks
Others
Anti-Counterfeit Packaging for Healthcare Segment by Application
Retail Chains
Internet Pharmacies
Others
Anti-Counterfeit Packaging for Healthcare Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Counterfeit Packaging for Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Counterfeit Packaging for Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Counterfeit Packaging for Healthcare.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-Counterfeit Packaging for Healthcare market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Counterfeit Packaging for Healthcare manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Counterfeit Packaging for Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-Counterfeit Packaging for Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Invisible Printing
- Embedded Image
- Digital Watermarks
- Hidden Marks
- Others
Applications
- Retail Chains
- Internet Pharmacies
- Others
Companies covered
- 3M Company
- Applied Dna Sciences, Inc
- E. I. Dupont
- Sicpa Holding SA
- Zebra Technologies Corporation
- Trutag Technologies Inc
- CCL Industries Inc
- Avery Dennison Corporation
- Shiner International, Inc
- R. R. Donnelley & Sons Company
- Impinj, Inc
- Essentra Plc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-Counterfeit Packaging for Healthcare Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-Counterfeit Packaging for Healthcare Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-Counterfeit Packaging for Healthcare Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-Counterfeit Packaging for Healthcare Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-Counterfeit Packaging for Healthcare Market Dynamics
- 2.1 Anti-Counterfeit Packaging for Healthcare Industry Trends
- 2.2 Anti-Counterfeit Packaging for Healthcare Industry Drivers
- 2.3 Anti-Counterfeit Packaging for Healthcare Industry Opportunities and Challenges
- 2.4 Anti-Counterfeit Packaging for Healthcare Industry Restraints
3 Anti-Counterfeit Packaging for Healthcare Market by Manufacturers
- 3.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-Counterfeit Packaging for Healthcare Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-Counterfeit Packaging for Healthcare Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-Counterfeit Packaging for Healthcare Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-Counterfeit Packaging for Healthcare Manufacturers, Product Type & Application
- 3.7 Global Anti-Counterfeit Packaging for Healthcare Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-Counterfeit Packaging for Healthcare Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-Counterfeit Packaging for Healthcare Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-Counterfeit Packaging for Healthcare Tier 1, Tier 2, and Tier 3
4 Anti-Counterfeit Packaging for Healthcare Market by Type
- 4.1 Anti-Counterfeit Packaging for Healthcare Type Introduction
- 4.1.1 Invisible Printing
- 4.1.2 Embedded Image
- 4.1.3 Digital Watermarks
- 4.1.4 Hidden Marks
- 4.1.5 Others
- 4.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Type
- 4.2.1 Global Anti-Counterfeit Packaging for Healthcare Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Type (2021-2032)
- 4.2.3 Global Anti-Counterfeit Packaging for Healthcare Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-Counterfeit Packaging for Healthcare Revenue by Type
- 4.3.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-Counterfeit Packaging for Healthcare Revenue by Type (2021-2032)
- 4.3.3 Global Anti-Counterfeit Packaging for Healthcare Revenue Market Share by Type (2021-2032)
5 Anti-Counterfeit Packaging for Healthcare Market by Application
- 5.1 Anti-Counterfeit Packaging for Healthcare Application Introduction
- 5.1.1 Retail Chains
- 5.1.2 Internet Pharmacies
- 5.1.3 Others
- 5.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Application
- 5.2.1 Global Anti-Counterfeit Packaging for Healthcare Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Application (2021-2032)
- 5.2.3 Global Anti-Counterfeit Packaging for Healthcare Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-Counterfeit Packaging for Healthcare Revenue by Application
- 5.3.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-Counterfeit Packaging for Healthcare Revenue by Application (2021-2032)
- 5.3.3 Global Anti-Counterfeit Packaging for Healthcare Revenue Market Share by Application (2021-2032)
6 Global Anti-Counterfeit Packaging for Healthcare Sales by Region
- 6.1 Global Anti-Counterfeit Packaging for Healthcare Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-Counterfeit Packaging for Healthcare Sales by Region (2021-2032)
- 6.2.1 Global Anti-Counterfeit Packaging for Healthcare Sales by Region (2021-2026)
- 6.2.2 Global Anti-Counterfeit Packaging for Healthcare Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-Counterfeit Packaging for Healthcare Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-Counterfeit Packaging for Healthcare Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-Counterfeit Packaging for Healthcare Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-Counterfeit Packaging for Healthcare Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-Counterfeit Packaging for Healthcare Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-Counterfeit Packaging for Healthcare Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-Counterfeit Packaging for Healthcare Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-Counterfeit Packaging for Healthcare Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-Counterfeit Packaging for Healthcare Revenue by Region
- 7.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Region
- 7.1.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-Counterfeit Packaging for Healthcare Revenue by Region (2021-2026)
- 7.1.3 Global Anti-Counterfeit Packaging for Healthcare Revenue by Region (2027-2032)
- 7.1.4 Global Anti-Counterfeit Packaging for Healthcare Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-Counterfeit Packaging for Healthcare Revenue (2021-2032)
- 7.2.2 North America Anti-Counterfeit Packaging for Healthcare Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-Counterfeit Packaging for Healthcare Revenue (2021-2032)
- 7.3.2 Europe Anti-Counterfeit Packaging for Healthcare Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-Counterfeit Packaging for Healthcare Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-Counterfeit Packaging for Healthcare Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-Counterfeit Packaging for Healthcare Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-Counterfeit Packaging for Healthcare Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 3M Company
- 8.1.1 3M Company Company Information
- 8.1.2 3M Company Business Overview
- 8.1.3 3M Company Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 3M Company Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.1.5 3M Company Recent Developments
- 8.2 Applied Dna Sciences, Inc
- 8.2.1 Applied Dna Sciences, Inc Company Information
- 8.2.2 Applied Dna Sciences, Inc Business Overview
- 8.2.3 Applied Dna Sciences, Inc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Applied Dna Sciences, Inc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.2.5 Applied Dna Sciences, Inc Recent Developments
- 8.3 E. I. Dupont
- 8.3.1 E. I. Dupont Company Information
- 8.3.2 E. I. Dupont Business Overview
- 8.3.3 E. I. Dupont Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 E. I. Dupont Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.3.5 E. I. Dupont Recent Developments
- 8.4 Sicpa Holding SA
- 8.4.1 Sicpa Holding SA Company Information
- 8.4.2 Sicpa Holding SA Business Overview
- 8.4.3 Sicpa Holding SA Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sicpa Holding SA Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.4.5 Sicpa Holding SA Recent Developments
- 8.5 Zebra Technologies Corporation
- 8.5.1 Zebra Technologies Corporation Company Information
- 8.5.2 Zebra Technologies Corporation Business Overview
- 8.5.3 Zebra Technologies Corporation Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zebra Technologies Corporation Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.5.5 Zebra Technologies Corporation Recent Developments
- 8.6 Trutag Technologies Inc
- 8.6.1 Trutag Technologies Inc Company Information
- 8.6.2 Trutag Technologies Inc Business Overview
- 8.6.3 Trutag Technologies Inc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Trutag Technologies Inc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.6.5 Trutag Technologies Inc Recent Developments
- 8.7 CCL Industries Inc
- 8.7.1 CCL Industries Inc Company Information
- 8.7.2 CCL Industries Inc Business Overview
- 8.7.3 CCL Industries Inc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 CCL Industries Inc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.7.5 CCL Industries Inc Recent Developments
- 8.8 Avery Dennison Corporation
- 8.8.1 Avery Dennison Corporation Company Information
- 8.8.2 Avery Dennison Corporation Business Overview
- 8.8.3 Avery Dennison Corporation Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Avery Dennison Corporation Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.8.5 Avery Dennison Corporation Recent Developments
- 8.9 Shiner International, Inc
- 8.9.1 Shiner International, Inc Company Information
- 8.9.2 Shiner International, Inc Business Overview
- 8.9.3 Shiner International, Inc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shiner International, Inc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.9.5 Shiner International, Inc Recent Developments
- 8.10 R. R. Donnelley & Sons Company
- 8.10.1 R. R. Donnelley & Sons Company Company Information
- 8.10.2 R. R. Donnelley & Sons Company Business Overview
- 8.10.3 R. R. Donnelley & Sons Company Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 R. R. Donnelley & Sons Company Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.10.5 R. R. Donnelley & Sons Company Recent Developments
- 8.11 Impinj, Inc
- 8.11.1 Impinj, Inc Company Information
- 8.11.2 Impinj, Inc Business Overview
- 8.11.3 Impinj, Inc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Impinj, Inc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.11.5 Impinj, Inc Recent Developments
- 8.12 Essentra Plc
- 8.12.1 Essentra Plc Company Information
- 8.12.2 Essentra Plc Business Overview
- 8.12.3 Essentra Plc Anti-Counterfeit Packaging for Healthcare Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Essentra Plc Anti-Counterfeit Packaging for Healthcare Product Portfolio
- 8.12.5 Essentra Plc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-Counterfeit Packaging for Healthcare Value Chain Analysis
- 9.1.1 Anti-Counterfeit Packaging for Healthcare Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-Counterfeit Packaging for Healthcare Production Mode & Process
- 9.2 Anti-Counterfeit Packaging for Healthcare Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-Counterfeit Packaging for Healthcare Distributors
- 9.2.3 Anti-Counterfeit Packaging for Healthcare Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst